Turoctocog alfa pegol Active Not Recruiting Phase 3 Trials for Hemophilia As / Congenital Hematological Disorder Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02137850Safety and Efficacy of Turoctocog Alfa Pegol (N8-GP) in Previously Untreated Patients With Haemophilia A